(Q37609357)

21 August 2017

title

Cost effectiveness of methylphenidate versus AMP/DEX mixed salts for the first-line treatment of ADHD. (English)

1 reference

cost-effectiveness analysis

21 August 2017

main subject

1 reference

Sangeeta Narayan

1

1 reference

21 August 2017

Joel Hay

series ordinal

2

1 reference

21 August 2017

publication date

1 December 2004

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

21 August 2017

published in

1 reference

21 August 2017

volume

4

1 reference

21 August 2017

issue

6

1 reference

21 August 2017

page(s)

625-634

1 reference

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737167.4.6.625

Methylphenidate in children with hyperactivity: review and cost-utility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.4.6.625

Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.4.6.625

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.4.6.625

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.4.6.625

Side effects of dextroamphetamine and methylphenidate in hyperactive children--a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.4.6.625

21 January 2018

Identifiers

DOI

10.1586/14737167.4.6.625

1 reference

21 August 2017

1 reference